The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Gale, N. W., Holland, S. J., Valenzuela, D. M., Flenniken, A., Pan, L., Ryan, T. E., Henkemeyer, M., Strebhardt, K., Hirai, H., Wilkinson, D. G., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80276-7 · Cited by 839
Protein phosphatases and the regulation of mitogen-activated protein kinase signalling
Keyse, S. M. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00075-7 · Cited by 807
Binding of SH2 Domains of Phospholipase Cγ1, GAP, and Src to Activated Growth Factor Receptors
Anderson, D., Koch, C. A., Grey, L., Ellis, C., Moran, M. F., & Pawson, T. (1990) · Science · doi:10.1126/science.2173144 · Cited by 594
Miao, H., Burnett, E., Kinch, M., Simon, E., & Wang, B. (2000) · Nature Cell Biology · doi:10.1038/35000008 · Cited by 548
Self-citationReduced MAP Kinase Phosphatase-1 Degradation After p42/p44 MAPK -Dependent Phosphorylation
Brondello, J.-M., Pouysségur, J., & McKenzie, F. R. (1999) · Science · doi:10.1126/science.286.5449.2514 · Cited by 419
Holland, S. J., Gale, N. W., Gish, G. D., Roth, R. A., Songyang, Z., Cantley, L. C., Henkemeyer, M., Yancopoulos, G. D., & Pawson, T. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3877 · Cited by 271
Overexpression of the EphA2 tyrosine kinase in prostate cancer
Walker-Daniels, J., Coffman, K., Azimi, M., Rhim, J. S., Bostwick, D. G., Snyder, P., Kerns, B. J., Waters, D. J., & Kinch, M. S. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19991201)41:4<275::aid-pros8>3.0.co;2-t · Cited by 269
Self-citation(2002) · Wiley eBooks · doi:10.1002/0471221201 · Cited by 262
Cited by
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Pasquale, E. B. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2806 · Cited by 1,226
Mechanisms and functions of eph and ephrin signalling
Kullander, K., & Klein, R. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm856 · Cited by 1,156
Kindling and status epilepticus models of epilepsy: rewiring the brain
Morimoto, K., Fahnestock, M., & Racine, R. J. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.03.009 · Cited by 838
Huber, A. B., Kolodkin, A. L., Ginty, D. D., & Cloutier, J.-F. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081139 · Cited by 719
Miao, H., Li, D.-Q., Mukherjee, A., Guo, H., Petty, A., Cutter, J., Basilion, J. P., Sedor, J., Wu, J., Danielpour, D., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.009 · Cited by 533
Self-citationDiverse Roles of Eph Receptors and Ephrins in the Regulation of Cell Migration and Tissue Assembly
Poliakov, A., Cotrina, M., & Wilkinson, D. G. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.09.006 · Cited by 436
Eph Receptor Signaling and Ephrins
Lisabeth, E. M., Falivelli, G., & Pasquale, E. B. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009159 · Cited by 425
`Eph'ective signaling: forward, reverse and crosstalk
Murai, K. K., & Pasquale, E. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00625 · Cited by 363
The role of ephrins and Eph receptors in cancer
Surawska, H., Ma, P. C., & Salgia, R. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.09.002 · Cited by 341
Therapeutic targeting of EPH receptors and their ligands
Boyd, A. W., Bartlett, P. F., & Lackmann, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4175 · Cited by 341
The ephrins and Eph receptors in angiogenesis
Cheng, N., Brantley, D. M., & Chen, J. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00031-4 · Cited by 334
Angiogenesis and signal transduction in endothelial cells
Mu�oz-Ch�puli, R., Quesada, A. R., & �ngel Medina, M. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4070-7 · Cited by 333
Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles
Tanaka, T., Mangala, L. S., Vivas-Mejia, P. E., Nieves-Alicea, R., Mann, A. P., Mora, E., Han, H.-D., Shahzad, M. M. K., Liu, X., Bhavane, R., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3931 · Cited by 316
Kinase-Independent Requirement of EphB2 Receptors in Hippocampal Synaptic Plasticity
Grunwald, I. C., Korte, M., Wolfer, D., Wilkinson, G. A., Unsicker, K., Lipp, H.-P., Bonhoeffer, T., & Klein, R. (2001) · Neuron · doi:10.1016/s0896-6273(01)00550-5 · Cited by 306
The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
Wykosky, J., & Debinski, W. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0244 · Cited by 300
EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme
Wykosky, J., Gibo, D. M., Stanton, C., & Debinski, W. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0056 · Cited by 290
Signalling mechanisms mediating neuronal responses to guidance cues
Guan, K.-L., & Rao, Y. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1254 · Cited by 289
The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl–Crk pathway
Noren, N. K., Foos, G., Hauser, C. A., & Pasquale, E. B. (2006) · Nature Cell Biology · doi:10.1038/ncb1438 · Cited by 288
Direct cell–cell contact with the vascular niche maintains quiescent neural stem cells
Ottone, C., Krusche, B., Whitby, A., Clements, M., Quadrato, G., Pitulescu, M. E., Adams, R. H., & Parrinello, S. (2014) · Nature Cell Biology · doi:10.1038/ncb3045 · Cited by 282
Martin, G. S. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00216-2 · Cited by 281
Brantley-Sieders, D. M., Zhuang, G., Hicks, D., Fang, W. B., Hwang, Y., Cates, J. M. M., Coffman, K., Jackson, D., Bruckheimer, E., Muraoka-Cook, R. S., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33154 · Cited by 278
Netrin-1-mediated axon outgrowth requires deleted in colorectal cancer-dependent MAPK activation
Forcet, C., Stein, E., Pays, L., Corset, V., Llambi, F., Tessier-Lavigne, M., & Mehlen, P. (2002) · Nature · doi:10.1038/nature748 · Cited by 273
Multiple roles of ephrins in morphogenesis, neuronal networking, and brain function
Palmer, A., & Klein, R. (2003) · Genes & Development · doi:10.1101/gad.1093703 · Cited by 272
A conditional feedback loop regulates Ras activity through EphA2
Macrae, M., Neve, R. M., Rodriguez-Viciana, P., Haqq, C., Yeh, J., Chen, C., Gray, J. W., & McCormick, F. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.005 · Cited by 260
Young, A., Lou, D., & McCormick, F. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0231 · Cited by 211
EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma
Thaker, P. H., Deavers, M., Celestino, J., Thornton, A., Fletcher, M. S., Landen, C. N., Kinch, M. S., Kiener, P. A., & Sood, A. K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0589 · Cited by 211
The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas
Han, L., Dong, Z., Qiao, Y., Kristensen, G. B., Holm, R., Nesland, J. M., & Suo, Z. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.06.036 · Cited by 68
Druggable Orthosteric and Allosteric Hot Spots to Target Protein-protein Interactions
Ma, B., & Nussinov, R. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990073 · Cited by 45
Metadata
- Authors
- Miao, H., Wei, B.-R., Peehl, D. M., Li, Q., Alexandrou, T., Schelling, J. R., Rhim, J. S., Sedor, J. R., Burnett, E., & Wang, B.
- Venue
- Nature Cell Biology
- Published
- 2001-04-11
- Volume
- 3
- Issue
- 5
- Pages
- 527-530
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W1597741096
- Cited by
- 358
- References
- 19
- FWCI
- 9.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.